What is the Ifamilysc Co. Ltd. stock price forecast?

Ifamilysc Co. Ltd. is currently trading at ₩9,470. View real-time AI analysis on Alpha Lenz.

What is Ifamilysc Co. Ltd. insider trading activity?

View the latest insider trading data for Ifamilysc Co. Ltd. on Alpha Lenz.

What is Ifamilysc Co. Ltd.'s P/E ratio?

Ifamilysc Co. Ltd.'s P/E ratio is 7.5.

Ifamilysc Co. Ltd.

KRX · 114840

₩9,470+350(+3.84%)Market closed

Ask about Ifamilysc Co. Ltd.'s future dividend policy...

Alpha Chat Insight

“Ifamilysc Co. Ltd. trades at a P/E of 7.5 (undervalued) with strong ROE of 22.3%. 3Y revenue CAGR of 38.0% highlights clear growth momentum.”

Ask for details →

Company Overview

Ifamilysc Co. Ltd. is a diversified life sciences company primarily engaged in the research, development, and commercialization of pharmaceutical products. The company operates in the health sector, focusing on providing innovative solutions to complex health challenges. Ifamilysc Co. Ltd. specializes in drug development for a range of therapeutic areas, including oncology and cardiovascular diseases, impacting significant sectors such as healthcare and biotechnology. Its operations extend beyond manufacturing, including a strong emphasis on research and development, which plays a crucial role in advancing medical treatments. Ifamilysc Co. Ltd.'s market significance is underlined by its commitment to improving patient outcomes and contributing to the broader objectives of global health improvement through scientific innovation and collaboration.

CEO김태욱, 김성현

Websitehttps://www.ifamily.co.kr

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩164,019,453,000Market Cap

₩224,096,054,180Revenue

17.32MShares Out

0Employees

Margins

39.39%Gross

13.53%EBITDA

12.11%Operating

12.30%Pre-Tax

9.74%Net

Valuation

7.51P/E

1.57P/B

0.73EV/Sales

4.76EV/EBITDA

4.06P/FCF

Growth (CAGR)

37.96%Rev 3Yr

23.12%Rev 5Yr

41.83%Op Inc 3Yr

18.46%Op Inc 5Yr

41.92%Net Inc 3Yr

20.08%Net Inc 5Yr

Returns

16.50%ROA

22.28%ROE

21.12%ROIC

Financial Health

₩31,968,345,950Cash & Cash Equivalents

₩5,968,215,840Net Debt

36.32%Debt/Equity

N/AInterest Cov